# Assessment of Oxidative Stress Markers in the Upper and Lower Airways of Atopic Children Treated With Nebulized Beclomethasone

> **NCT01113489** · PHASE3 · COMPLETED · sponsor: **Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy** · enrollment: 32 (estimated)

## Conditions studied

- Asthma
- Allergic Rhinitis

## Interventions

- **DRUG:** beclomethasone dipropionate
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01113489
- **Lead sponsor:** Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2010-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01113489

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01113489, "Assessment of Oxidative Stress Markers in the Upper and Lower Airways of Atopic Children Treated With Nebulized Beclomethasone". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01113489. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*